7
Total investments
1
Early stage
2
Mid stage
1
Late stage
3y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Jan 2026
NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinsons disease, essential tremor, epilepsy, and depression.
Pre-seed Investor
Jan 2026
Diffraqtion is a Somerville, MA, space startup building the world’s first quantum camera powering the largest ultra-high-resolution imaging satellite network. Combining quantum photonics and AI, Diffraqtion enables machines to see further and think faster, advancing space exploration, defense, and intelligent systems worldwide.
Seed Investor
Nov 2025
GenPeach AI is a research lab pushing the boundaries of foundation generative models.
We aim to redefine how people create and interact through multimodal, emotionally-aware AI.
Investor & Board Observer
Nov 2024
Familiar Machines and Magic, Inc. (FM&M) is a Massachusetts company using robotics and AI to develop health-related solutions. Founded by Colin Angle, the founder & former CEO of iRobot; Chris Jones, the former CTO of iRobot; and Ira Renfrew, the former CPO of Outrider, FM&M is assembling a world-class team of experts in robotics and AI. Familiar Machines and Magic, Inc is currently in stealth mode.
Investor
Sep 2023
TileDB is foundational software designed by scientists for scientific discovery.
TileDB structures all data types, including that data that does not fit into relational databases built for structured tabular data. Built on a powerful shape-shifting array database, TileDB handles the complexities of non-traditional “unstructured” multimodal data, such as genomic variants, bulk and single-cell transcriptomics, proteomics, biomedical imaging, as well as the frontier data of the future.
Used by science and data teams within big pharma and biotechs to power their multiomic FAIR data platforms, TileDB is the destination for scientific breakthroughs where frontier multimodal data is driving drug discovery.
Investor
Jun 2023
Phoenix Tailings is pioneering the future of clean mining and metals production.
We are dedicated to building the world’s first fully clean mining and refining company, producing the critical metals needed for the next generation of technology and infrastructure. By harvesting valuable materials directly from mining tailings, we eliminate waste streams while creating a sustainable and domestic supply of rare earths and other essential resources.
We are already commercially shipping rare earth metals and alloys to magnet customers today, proving both the scalability and impact of our approach. Our breakthrough refining model provides a clean and reliable supply chain, empowering industries from defense and aerospace to electric vehicles, renewable energy, and medical technologies.
Phoenix Tailings has been commercially shipping rare earth metal products since 2023, demonstrating our leadership in bringing sustainable solutions to market.
Experience · 9 entries
All (9)
Investments (7)
Founder (1)
Board (1)
2026
Seed Investor
Jan 2026
NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinsons disease, essential tremor, epilepsy, and depression.
Pre-seed Investor
Jan 2026
Diffraqtion is a Somerville, MA, space startup building the world’s first quantum camera powering the largest ultra-high-resolution imaging satellite network. Combining quantum photonics and AI, Diffraqtion enables machines to see further and think faster, advancing space exploration, defense, and intelligent systems worldwide.
Co-Founder & Managing Partner
Jan 2026
Aether VC is a venture capital firm backing frontier deep-tech companies across AI, robotics, quantum technologies, physical intelligence, and advanced systems.
The firm is co-founded by entrepreneurs and operators with experience building and scaling category-defining technology companies, including unicorns, alongside world-class engineers and researchers.
We invest across stages, partnering with companies from early technical inflection points through growth, and work closely with founders on technical validation, strategic partnerships, commercialization, and long-term scale.
Aether VC is built on a global platform spanning leading research institutions, industrial partners, and technology ecosystems across the US, Europe, and Asia.
2025
Seed Investor
Nov 2025
GenPeach AI is a research lab pushing the boundaries of foundation generative models.
We aim to redefine how people create and interact through multimodal, emotionally-aware AI.
Show all 9 entries ↓
Investment activity
2023–2026 · 7 investments
Recent (last 2 years)Earlier
